Having a fairly large position on RMD, i am concerned about the prospect now.
The numbers are looking ugly when quarterly are lined up instead of looking at quarter on quater growth.
On top of the wellknown Growth Margin decline, quarterly top line revenues are on the decline as well.
Compounded by the decline in margin, net income performance is even worse.
If someone can shed light on the future growh prospect of RMD, it would be very helpful. personally i will give it another quarter, will trim position if no rebond of Revenue or Margin if not both.
Ann: ResMed Announces Results for the First Quarter of FY2024, page-31
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$32.66 |
Change
0.140(0.43%) |
Mkt cap ! $20.99B | |||
| Open | High | Low | Value | Volume |
| $32.56 | $32.67 | $32.41 | $33.93M | 1.040M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3261 | $32.59 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $32.66 | 11222 | 2 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| RMD (ASX) Chart |